← Full evidence page

For the cleanest result, disable browser headers and footers.

Dediabetes Evidence Brief

Bone Mineral Density in Diabetes Evidence

Evidence related to bone mineral density and bone mineral content outcomes in diabetes studies.

Brief accessed
—

Full evidence pagehttps://www.dediabetes.com/evidence/bone-mineral-density

Executive Summary

Bone Mineral Density evidence appears to center on Eldecalcitol.

Among 6 indexed studies and 7 interventions, the strongest signals are summarized from the available evidence. Dapagliflozin has been studied often, while Eldecalcitol appears to have stronger current evidence signals.

  • No strong consistent positive evidence pattern was detected.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Evidence Snapshot

Studies analyzed
6
Evidence relationships
10
Interventions
7
Outcomes
4
Strong evidence signals
0
Mixed evidence areas
0

Key Findings

  1. 01

    Across 1 study, Vitamin D supplementation shows a strong positive signal for Bone mineral content (BMC).

  2. 02

    Across 1 study, Dapagliflozin shows a neutral signal for Bone mineral density (BMD).

  3. 03

    Across 1 study, Eldecalcitol shows a strong positive signal for Bone mineral density (BMD).

  4. 04

    Across 1 study, Gastric bypass shows a evidence signal for Bone mineral density (BMD).

Question Highlights

What improves bone mineral density?

Dapagliflozin, Eldecalcitol, and Gastric bypass are among the most studied approaches for Bone Mineral Density.

Vitamin D supplementation, Eldecalcitol, and MyPlan 2.0 are among the best-supported options in the available evidence across 6 studies.

Consistency cannot yet be determined.

Read the full answer

How can I lower bone mineral density (bmd)?

Dapagliflozin, Eldecalcitol, and Gastric bypass are among the most studied approaches for Bone mineral density (BMD).

Emerging evidence is based on 5 supporting studies.

Consistency cannot yet be determined.

Read the full answer

Evidence Categories

The evidence is organized by how consistently it supports a conclusion and how much research is available.

Well-Supported Interventions

The strongest and most consistent evidence for improving this outcome.

No strong consistent positive evidence pattern was detected.

Interpretation

The current evidence does not yet show a clear consistent-benefit pattern.

Findings Requiring Careful Interpretation

Results that vary across studies or depend on population, study design, duration, or comparator.

Some evidence is positive, but results are not consistent across all studies.

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

MyPlan 2.0 is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Leading examples

MyPlan 2.0

Evidence basis: 1 evidence pair - 1 study

Emerging Areas of Research

Early positive signals that require additional high-quality research.

Early findings are encouraging, but stronger trials are needed.

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Eldecalcitol may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Leading examples

Eldecalcitol · MyPlan 2.0 · Vitamin D supplementation

Evidence basis: 4 evidence pairs - 3 studies

About this Evidence Brief

This brief summarizes research currently indexed by Dediabetes Evidence Intelligence. It is not a clinical guideline or personalized medical recommendation. Evidence classifications may change as additional studies are indexed.

Suggested citation

—